Every Form 4 that Enova Intl Inc (ENVA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ENVA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENVA filings page.
Enova International CEO Steven E. Cunningham reported routine equity transactions. On January 30, 2026, he exercised a non-qualified stock option for 11,436 shares of common stock at an exercise price of $20.73 per share, increasing his direct holdings to 139,155 shares.
That same day, he sold 11,436 shares of Enova common stock in market transactions at a weighted average price of $165.1307 per share, leaving him with 127,719 shares directly owned after the sale. The option and a related stock appreciation right had been granted in tandem and fully vested by February 11, 2023.
Enova International’s General Counsel and Secretary, Sean Rahilly, reported an option exercise and share sale. On 01/30/2026, he exercised 12,879 non-qualified stock options at an exercise price of $20.73 per share, receiving 12,879 common shares.
That same day, he sold 12,879 common shares at a weighted average price of $164.2821, from multiple trades between $163.415 and $164.95. After these transactions, he directly held 100,877 shares of common stock and 15,000 non-qualified stock options.
Enova International Executive Chairman David Fisher reported exercising stock options and selling shares of the company’s common stock. On January 30, 2026, he exercised a non-qualified stock option for 37,989 shares of Enova common stock at an exercise price of $23.96 per share.
On the same day, he sold 37,989 shares of Enova common stock at a weighted average price of $165.315 per share, with individual trade prices ranging from $163.885 to $166.73. Following these transactions, Fisher directly held 348,223 shares of Enova common stock. The option for 37,989 shares, which vested in three annual installments from February 2020 through February 2022, was fully exercised and no longer outstanding.
Enova International Executive Chairman David Fisher reported an option exercise and share sale. On January 26, 2026, he exercised a non-qualified stock option for 9,573 shares of common stock at an exercise price of $23.96 per share. The same day, he sold 9,573 shares of common stock at a weighted average price of $157.805 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, Fisher directly held 348,223 shares of Enova common stock and 37,989 derivative securities (stock options) linked to common shares.
Enova International director reports share transfer. A director of Enova International, Inc. reported a transaction involving the company’s common stock on 12/22/2025. The filing shows a disposition of 2,558 shares of common stock with a reported price of $0, consistent with a non-cash transfer such as a gift. Following this transaction, the reporting person holds 73,651 shares of Enova common stock in direct ownership.
Enova International, Inc. chief executive officer and director Mr. Fisher reported option exercises and share sales in company stock. On 12/16/2025, he exercised a non-qualified stock option for 15,000 shares of common stock at an exercise price of $23.96 per share and acquired those shares. On the same day, he sold 15,000 shares of common stock at a weighted average price of $160.244 per share under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he beneficially owned 348,223 shares of common stock directly and held 47,562 derivative securities in the form of stock options. The reported options had vested in three equal installments on February 12 of 2020, 2021, and 2022.
Enova International, Inc. (ENVA) Chief Executive Officer and director David Fisher reported an equity transaction involving company stock. On 11/21/2025, he exercised a non-qualified stock option to acquire 6,000 shares of common stock at an exercise price of $23.96 per share and, on the same date, sold 6,000 shares of common stock in an open market transaction at a weighted average price of $124.2548 per share.
After these transactions, Fisher beneficially owned 348,223 shares of Enova common stock directly and held 62,562 derivative securities in the form of stock options. The filing notes that the sale was made under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to sell shares according to a predetermined schedule.
Enova International (ENVA) reported an insider equity grant to its Chief Strategy Officer. The filing shows a non‑qualified stock option with a limited SAR for 3,878 shares at an $128 exercise price, granted on November 6, 2025 and expiring on November 6, 2032.
The options vest in three substantially equal installments on November 6, 2026, November 6, 2027, and November 6, 2028. The SAR is exercisable only from the day after a defined “Change in Control” through the 30th day thereafter and pays the product of the excess of the “Offer Value Per Share” over the option price times shares exercised, and only if an “Offer” (as defined) is made.
Enova International (ENVA) disclosed that officer Sean Rahilly reported a grant of 2,310 non‑qualified stock options with a limited SAR on November 6, 2025 at an exercise price of $128 per share. The options vest in substantially equal one‑third increments on November 6, 2026, November 6, 2027, and November 6, 2028, and expire on November 6, 2032.
The tandem SAR may be exercised only during the 30‑day period beginning after a Change in Control, and pays based on the defined Offer Value Per Share above the option exercise price, if an Offer is made.
Enova International (ENVA) reported an insider equity award. The company’s CFO and director received a grant of 6,144 non‑qualified stock options with a limited SAR at an exercise price of $128 on November 6, 2025. The options expire November 6, 2032 and vest in three substantially equal annual installments on November 6, 2026, November 6, 2027, and November 6, 2028.
The tandem SAR is exercisable only after a “Change in Control” and within 30 days thereafter, and pays the excess of the “Offer Value Per Share” over the exercise price, subject to an “Offer.”
Enova International (ENVA) reported an insider equity award. The CEO and director received 20,793 non‑qualified stock options with a limited stock appreciation right at an exercise price of $128 on November 6, 2025.
The options vest in substantially equal one‑third increments on November 6, 2026, November 6, 2027, and November 6, 2028, and expire on November 6, 2032. Following the grant, 20,793 derivative securities were beneficially owned in direct form.
Enova International (ENVA) disclosed insider transactions by its Chief Financial Officer and director. On 10/29/2025, the reporting person exercised stock options for 11,436 shares at an exercise price of $20.73 per share. The same day, they sold 11,436 shares at a weighted average price of $120.76, with trades executed between $120.52 and $121.00. A separate sale of 3,438 shares occurred at $120.50.
After these transactions, the reporting person directly owned 127,719 shares of Enova common stock. The filing notes the options were part of a non-qualified stock option with a limited stock appreciation right granted in tandem and previously vested in thirds on February 11 of 2021, 2022, and 2023.
Enova International (ENVA) reported insider activity by CEO and director David Fisher. On 10/27/2025, he exercised 6,000 stock options at an exercise price of $23.96 and sold 6,000 common shares at a weighted average price of $122.6111, executed in multiple trades ranging from $120.36 to $126.2732. The sale was made pursuant to a Rule 10b5-1 trading plan.
Following these transactions, Fisher directly beneficially owns 348,223 shares of common stock. He also reports 68,562 derivative securities (non-qualified stock options with a limited stock appreciation right) remaining outstanding.
David Fisher, Chief Executive Officer and Director of Enova International, Inc. (ENVA), reported option exercises and subsequent share sales on September 17 and September 19, 2025. Mr. Fisher exercised option rights at an exercise price of $23.96 to acquire 35,000 shares on 09/17/2025 and 6,000 shares on 09/19/2025. On the same dates he sold 35,000 shares (weighted-average sale price $125.5488) and 6,000 shares (weighted-average sale price $125.8924), respectively. The filings disclose the sales were executed in multiple trades at specified price ranges and note that the sale(s) were effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan. Following these transactions, Mr. Fisher’s reported beneficial ownership is 348,223 shares.